Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$122,708,762
+$19,955,601 QoQ
Shares Held
954,932
+11.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#191
of 3,778 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $2,118,676,056 across 8 Drug Manufacturers - General names. MRK ranks #2 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
9,357,390 | $1,774,348,291 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
954,932 | $122,708,762 | |
| 3 | NVO |
Novo Nordisk A S
|
1,677,615 | $80,424,863 | |
| 4 | BIIB |
Biogen Inc.
|
278,283 | $60,125,824 | |
| 5 | PFE |
Pfizer Inc
|
1,916,801 | $46,156,568 | |
| 6 | SNY |
Sanofi
|
804,056 | $34,301,028 | |
| 7 | GSK |
GSK plc
|
7,163 | $375,484 | |
| 8 | NVS |
Novartis AG
|
1,501 | $235,236 |
All Filings in MRK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,708,762 | 954,932 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $102,753,161 | 854,212 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $109,956,385 | 1,044,617 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $95,181,404 | 1,134,057 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $77,787,365 | 982,660 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $80,592,721 | 897,869 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $58,143,374 | 584,473 | Shares | Sole | 2025-02-13 | |
| 2020-06-30 | $62,952,369 | 814,074 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $111,950,884 | 1,455,042 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||